These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15281636)

  • 21. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
    Judge R; Parry MG; Quail D; Jacobson JG
    Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
    Farah A
    J Clin Psychiatry; 1999 Apr; 60(4):260-1. PubMed ID: 10221289
    [No Abstract]   [Full Text] [Related]  

  • 23. Antidepressants and suicide: a commentary on a significant contribution to this debate.
    Goldney RD
    Crisis; 2005; 26(2):97-8. PubMed ID: 16138748
    [No Abstract]   [Full Text] [Related]  

  • 24. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of selective serotonin reuptake inhibitors in childhood depression.
    Wohlfarth T; Lekkerkerker F; van Zwieten B
    Lancet; 2004 Aug 21-27; 364(9435):659-60; author reply 661. PubMed ID: 15325820
    [No Abstract]   [Full Text] [Related]  

  • 26. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients.
    Gülseren L; Gülseren S; Hekimsoy Z; Mete L
    Arch Med Res; 2005; 36(2):159-65. PubMed ID: 15847950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
    Sheffield RE; Lo Sasso AT; Young CH; Way K
    Adm Policy Ment Health; 2002 Nov; 30(2):121-39. PubMed ID: 12680617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction of serotonin re-uptake inhibitors with perhexiline.
    Alderman CP; Hundertmark JD; Soetratma TW
    Aust N Z J Psychiatry; 1997 Aug; 31(4):601-3. PubMed ID: 9272272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sociodemographic correlates of antidepressant utilisation in Australia. Comment.
    Simmons MB; Willet MR; Hetrick SE
    Med J Aust; 2009 Oct; 191(8):471. PubMed ID: 19835550
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
    Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
    J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 34. SSRIs: take your pick.
    Harv Ment Health Lett; 2002 May; 18(11):7. PubMed ID: 12021031
    [No Abstract]   [Full Text] [Related]  

  • 35. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are paroxetine, fluoxetine, and sertraline equally effective for depression?
    Straton JB; Cronholm P
    J Fam Pract; 2002 Mar; 51(3):285. PubMed ID: 11978244
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Paroxetine, hypothyroidism and, despite everything, inadequate antidiuretic hormone secretion].
    Prieto De Paula JM; Franco Hidalgo S; Ginés Santiago A; Nalotto L
    Endocrinol Nutr; 2011 Feb; 58(2):98-9. PubMed ID: 21334268
    [No Abstract]   [Full Text] [Related]  

  • 39. Paroxetine in the treatment of adolescent major depression.
    Correll CU; Pleak RR
    J Am Acad Child Adolesc Psychiatry; 2002 Nov; 41(11):1269; author reply 1270. PubMed ID: 12410065
    [No Abstract]   [Full Text] [Related]  

  • 40. Antidepressants and the risk of suicidal behaviors.
    Jick H; Kaye JA; Jick SS
    JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.